ADAR1 regulates melanoma cell invasiveness by controlling beta3-integrin via microRNA-30 family members

gan Nemlich, Yael, Besser, Michal J, Schachter, Jacob, Markel, Gal
Cyhoeddwyd yn Am J Cancer Res (2020)

Focus on Adoptive T Cell Transfer Trials in Melanoma

gan Hershkovitz, Liat, Schachter, Jacob, Treves, Avraham J., Besser, Michal J.
Cyhoeddwyd 2010

Multidisciplinary management of very advanced stage III and IV melanoma: Proof-of-principle

gan GUTMAN, HAIM, BEN-AMI, EYTAN, SHAPIRA-FROMMER, RONI, SCHACHTER, JACOB
Cyhoeddwyd 2012

miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1

gan Cohen, Ronit, Greenberg, Eyal, Nemlich, Yael, Schachter, Jacob, Markel, Gal
Cyhoeddwyd yn Oncotarget (2015)

SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells

gan Ashkenazi, Shira, Ortenberg, Rona, Besser, Michal, Schachter, Jacob, Markel, Gal
Cyhoeddwyd yn Oncotarget (2016)

Mutagen-Specific Mutation Signature Determines Global microRNA Binding

gan Greenberg, Eyal, Rechavi, Gideon, Amariglio, Ninette, Solomon, Oz, Schachter, Jacob, Markel, Gal, Eyal, Eran
Cyhoeddwyd 2011

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms

gan Sapoznik, Sivan, Hammer, Ohad, Ortenberg, Rona, Besser, Michal J., Ben-Moshe, Tehila, Schachter, Jacob, Markel, Gal
Cyhoeddwyd 2012

Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction

gan Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J.
Cyhoeddwyd yn Front Immunol (2021)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

gan Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Cyhoeddwyd yn Front Immunol (2017)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

gan Rozenbaum, Meir, Meir, Amilia, Aharony, Yarden, Itzhaki, Orit, Schachter, Jacob, Bank, Ilan, Jacoby, Elad, Besser, Michal J.
Cyhoeddwyd yn Front Immunol (2020)

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience

gan Asher, Nethanel, Israeli-Weller, Noa, Shapira-Frommer, Ronnie, Ben-Betzalel, Guy, Schachter, Jacob, Meirson, Tomer, Markel, Gal
Cyhoeddwyd yn Cancers (Basel) (2021)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients

gan Sapoznik Sivan, Faranesh Suzan, Ortenberg Rona, Hamburger Tamar, Barak Vivian, Peretz Tamar, Schachter Jacob, Markel Gal, Lotem Michal
Cyhoeddwyd 2012-01-01

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()

gan Kfir-Elirachman, Karin, Ortenberg, Rona, Vizel, Bella, Besser, Michal J, Barshack, Iris, Schachter, Jacob, Nemlich, Yael, Markel, Gal
Cyhoeddwyd yn Neoplasia (2018)

90. Fecal Microbiota Transplantation in Metastatic Melanoma Patients Resistant to Anti-PD-1 Treatment

gan Youngster, Ilan, Baruch, Erez, Katz, Lior, Lahat, Adi, Brosh-Nissimov, Tal, Schachter, Jacob, Koren, Omry, Markel, Gal, Boursi, Ben
Cyhoeddwyd yn Open Forum Infect Dis (2019)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex

gan Greenberg, Eyal, Hajdu, Steven, Nemlich, Yael, Cohen, Ronit, Itzhaki, Orit, Jacob-Hirsch, Jasmine, Besser, Michal J., Schachter, Jacob, Markel, Gal
Cyhoeddwyd 2014

Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack

gan Markel, Gal, Seidman, Rachel, Cohen, Yifat, Besser, Michal J, Sinai, Tali Cohen, Treves, Avraham J, Orenstein, Arie, Berger, Raanan, Schachter, Jacob
Cyhoeddwyd 2009

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns

gan Haik, Josef, Nardini, Gil, Goldman, Noga, Galore-Haskel, Gilli, Harats, Moti, Zilinsky, Isaac, Weissman, Oren, Schachter, Jacob, Winkler, Eyal, Markel, Gal
Cyhoeddwyd yn Oncotarget (2015)

Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors

gan Asher, Nethanel, Marom, Edith M., Ben‐Betzalel, Guy, Baruch, Erez Nissim, Steinberg‐Silman, Yael, Schachter, Jacob, Shapira‐Frommer, Ronnie, Markel, Gal
Cyhoeddwyd yn Oncologist (2019)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies

gan Besser, Michal J., Shoham, Tsipi, Harari-Steinberg, Orit, Zabari, Naama, Ortenberg, Rona, Yakirevitch, Arkadi, Nagler, Arnon, Loewenthal, Ron, Schachter, Jacob, Markel, Gal
Cyhoeddwyd 2013

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma

gan Galore-Haskel, Gilli, Baruch, Erez N., Berg, Amy L., Barshack, Iris, Zilinsky, Itzhak, Avivi, Camila, Besser, Michal J., Schachter, Jacob, Markel, Gal
Cyhoeddwyd yn Oncotarget (2017)